KOLMAR-BNH
Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724688710/en/
HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)
HemoHIM G (Global) is the international version of ‘HemoHIM’, Korea’s first individually-approved immune-boosting health supplement developed by Kolmar BNH over an eight-year period. The formulation has been tailored to comply with the food regulations of various countries, with adjustments made to raw materials and ingredient ratios. The product features angelica sinensis, ligusticum chuanxiong, paeonia lactiflora, all selected through rigorous quality control processes. Enhanced taste and aroma also make HemoHIM G more appealing to a broader audience.
In April, Kolmar BNH published a study on HemoHIM G in the SCIE-ranked journal Toxicological Research, demonstrating its safety. Conducted according to OECD guidelines, the study holds significance not only in facilitating safety approvals in other countries but also in reinforcing intellectual property rights with reliable results.
HemoHIM, distributed by Atomy, is a technologically-advanced product of Kolmar BNH. The main ingredient, HemoHIM extract complex of angelica gigas, etc., was developed in collaboration with the Korea Atomic Energy Research Institute. Currently, it is available in 19 countries, including Australia, the United States, Thailand, Central Asia, and South America.
Kolmar BNH continues its efforts in research and development to enhance HemoHIM’s global competitiveness including new functionalities, through investing about 4% of its annual revenues to R&D. In June, the company published a study showing that the main ingredient of HemoHIM (HemoHIM extract complex of angelica gigas, etc.), has antioxidant and anti-fatigue effects, which are newly discovered. This study was featured in the June issue of the ‘Journal of Medicinal Food,’ an SCIE-level international journal.
Leveraging the competitive edge of HemoHIM G, the company plans to speed up exports to European countries, including Turkey, Italy, and Belgium.
An official from Kolmar BNH said, “HemoHIM is Korea’s one of the best-selling health supplements, with cumulative sales of KRW 200 billion over the past nine years since 2014. We aim to build on our success in Korea and accelerate our expansion into the European market.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240724688710/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Osmose Acquires Centillion Solutions, Inc. to Expand Its Technical Services Capabilities28.10.2025 15:00:00 CET | Press release
Osmose Utilities, Inc. today announced that it has acquired Centillion Solutions, Inc., a leading engineering services company for the telecommunications industry. Centillion provides fiber optic engineering, design, drafting and geospatial services for Fiber-to-the X (FTTx) and Hybrid Fiber Coax Networks. Founded in 2007, the company has offices in the U.S., Netherlands, UK, Australia, as well as a global design and engineering operation center in India. The acquisition of Centillion Solutions will further position Osmose with the ability to serve as a single vendor of technical services for telecom companies, providing comprehensive turn-key solutions that include pre-design walkout, Outside Plant (OSP) design, make-ready and permitting, and post construction services. “The addition of Centillion expands Osmose’s ability to deliver a complete, end-to-end fiber engineering solution providing customers with one trusted partner for planning, design, and delivery at scale,” said Mike Ada
Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies28.10.2025 14:16:00 CET | Press release
Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies Aims to improve researcher access to disease-relevant cell models Strengthens Merck’s leadership in next-generation biology Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028493228/en/ Merck and Promega will co-develop novel technologies that advance drug discovery. The agreement unites Merck’s strength in organoids and synthetic chemistry with Promega's market leading assay and reporter technologies. Together, the companies aim to develop assays capable of tracking cellular activity in real time using an innovative reporter system within three-dimensional (3D)
Guidewire Signs Definitive Agreement to Acquire ProNavigator28.10.2025 14:00:00 CET | Press release
AI-powered knowledge management platform puts expertise at the fingertips of every insurance professional CONNECTIONS CONFERENCE--Guidewire (NYSE: GWRE) today announced that it has entered into a definitive agreement to acquire ProNav Technologies Ltd. (d/b/a ProNavigator), a knowledge management platform purpose-built for the P&C insurance industry. ProNavigator delivers precise, context-aware best practice information directly within insurance workflows, helping professionals work faster and more effectively. Its platform captures, connects, and surfaces institutional knowledge across claims, underwriting, and distribution. Used by 34 insurance organizations, including 12 shared customers with Guidewire, ProNavigator helps increase productivity, reduce claim cycle times, personalize customer service, and accelerate employee onboarding. Once the acquisition is complete, Guidewire will integrate ProNavigator’s insurance-trained intelligence across its platform, delivering advanced sear
Rimini Street Introduces Agentic AI ERP in Groundbreaking White Paper28.10.2025 14:00:00 CET | Press release
Rimini Street declares ERP Software dead and unveils Agentic AI ERP, a next generation, transformative ERP technology that delivers innovation faster, better and cheaper with more agility, deployed over existing ERP Software with no required, costly ERP upgrades Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the publication of its latest thought leadership white paper, The Rise of Agentic AI ERP. This landmark document presents a vision and roadmap for the next-generation technology and tools that will eventually replace today’s ERP Software which has become too big, complex, inflexible and expensive to meet the needs of a fast-changing world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028696910/en/ Rimini Street In
Gurobi Appoints Dr. Oliver Bastert as Chief Technology Officer28.10.2025 14:00:00 CET | Press release
Dr. Bastert leads Gurobi’s R&D team, advancing innovation in the company’s optimization technology. Gurobi Optimization, LLC, the leader in decision intelligence technology, is pleased to announce the appointment of Dr. Oliver Bastert to the role of Chief Technology Officer, leading the company’s Research and Development team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028639754/en/ Dr. Oliver Bastert, CTO, Gurobi Optimization "We are thrilled to have Dr. Bastert onboard as our Chief Technology Officer,” said Duke Perrucci, CEO of Gurobi Optimization. “Oliver plays a pivotal role in advancing our solver and driving innovation. As we continue our mission to bring optimization everywhere, his leadership will be instrumental." Dr. Bastert joined the Gurobi team in February and brings over 20 years of experience in B2B software, SaaS, and AI technologies. Prior to joining Gurobi, he served as Vice President of Product Man
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom